Low certaintyPoints to benefit
Pimobendan in preclinical dilated cardiomyopathy (Dobermanns)
PROTECT, 2012
Appraisal in preparation
Low certaintyPoints to benefit
PROTECT, 2012
Appraisal in preparation
Very low certaintyInconclusive
Kaplan, 2018 · Freid, 2021 · Freeman, 2022
Appraisal in preparation
No evidenceUntested